Clinical study of TJ-137 Tsumura Kami-kihi-to in patients with idiopathic thrombocytopenic purpura (ITP)

Clinical and Applied Thrombosis/Hemostasis

Volumn 2, Issue 3, 1996, Pages 213-218

  Sakuragawa, Nobuo ^a   Yasunaga, Kojiro ^b   Nomura, Takeo ^c   Akatsuka, Junichi ^d   Kuramoto, Atsushi ^e   Matsuda, Jyuzo ^f   Nomura, Shosaku ^b  

^a UNIVERSITY OF TOYAMA   (Japan)

^b KANSAI MEDICAL UNIVERSITY   (Japan)

^c NIPPON MEDICAL SCHOOL   (Japan)

^d JIKEI UNIVERSITY SCHOOL OF MEDICINE   (Japan)

^e HIROSHIMA UNIV SCHOOL OF MEDICINE   (Japan)

^f TEIKYO UNIVERSITY   (Japan)

Author keywords

Idiopathic thrombocytopenic purpura; Kami kihi to; Kampo medicine; PAIgG; Platelet

Indexed keywords

EID: 24044552705     PISSN: 10760296     EISSN: None     Source Type: Journal    
DOI: 10.1177/107602969600200312     Document Type: Article

References (18)

1. Karpatkin S. Autoimmune thrombocytopenic purpura. Blood 1980;56:329-43.
2. McMillan R. Chronic idiopathic thrombocytopenic purpura. N Engl J Med 1981;304:1135-47.
3. Yasunaga K. Statistical observations of the treatment of chronic ITP. The 1978 Annual Report of the Idiopathic Dyshematopoiesis Research Team, 1979; pp. 532-42.
4. Tsuruta M, Kodama A, Kanamori S, et al. Case report: a female child with idiopathic thrombocytopenic purpura in whom a kampo preparation seemed effective. Pediair Intern Med 1984;16:66-9.
5. Okushin H. Case report: a patient with idiopathic thrombocytopenic purpura in whom concomitant Kami-kihi-to enabled maintenance therapy. Kampo Shinryo 1990;9:24-8.
6. Imbach P, Barandun S, d'Apuzzo V, et al. High-dose intravenous gammaglobulin for idiopathic thrombocytopenic purpura in childhood. Lancet 1981;i:1228-31.
7. Ahn YS, Harrington WJ, Simon SR, Mylvaganam R, Pall LM, So AG. Danazol for the treatment of idiopathic thrombocytopenic purpura. N Engl J Med 1983;308:1396-9.
8. Nomura T, Maekawa T, Dan K. Treatment of idiopathic thrombocytopenic purpura with danazol: a multicenter study. 1984 Annual Report of the Idiopathic Dyshematopoiesis Research Team, 1985; pp. 344-50.
9. Nomura S, Yanabu M, Fukuroi C, et al. Comparison of therapeutic effects of three drugs (neurotropin, ascorbate, Kamikihi-to) for idiopathic thrombocytopenic purpura. Ther Res 1992;13:2433-41.
10. Kuramoto A, Fujimura K, Takada N, Nomura T. Multicenter pilot study of the effects of ascorbate in refractory ITP. 1989 Annual Report of the Idiopathic Thrombocytopenic Research Team, 1990; pp. 124-7.
11. Obata S, Kimura K, Maeda K. Case report: a patient with idiopathic thrombocytopenic purpura in whom concomitant Sairei-to was useful to reduce the dose of adreno-cortical hormone. Jpn J Oriental Med 1990;41:99-101.
12. Araikawa K, Matsuzawa H, Sakurada T, Kato K, Kashiwakura C. Clinical investigation of Tsumura Sho-saiko-to in idiopathic thrombocytopenic purpura (ITP). Kampo Igaku 1990;14:204-6.
13. Araikawa K, Katsushima I, Sakurada T, Kato K, Furukawa Y. Effect of Tsumura Sho-saiko-to on idiopathic thrombocytopenic purpura (ITP). Kampo Igaku 1991;15:402-5.
14. Nakamura S, Yabe H, Nagai K. Treatment of idiopathic thrombocytopenic purpura with kampo medicine. Gendai Toyo Igaku 1991;12(1):160-3.
15. Chikuda K, Suenaga T. Therapeutic effect of Sairei-to in idiopathic thrombocytopenic purpura. Gendai Toyo Igaku 1991;12(1):164-9.
16. Wada H, Yokoyama T, Kobayashi M, et al. Experience in the treatment of idiopathic thrombocytopenic purpura with Tsumura Sho-saiko-to. Kampo Igaku 1992;16:425-7.
17. Sakuragawa N, Ejiri N, Hayakawa Y, Furuoka Y, Nakagawa M, Shimazaki C. Kami-kihi-to, its therapeutic effect in ITP patients and effect of IL-6 production in mice. Proceedings of the 9th Congress of the Society of Wakan Yaku, 1992; p. 96.
18. Nomura S, Yamaguchi K, Kido H, et al. Effects of Kamikihi-to on antiplatelet antibodies and immune complexes in ITP patients. Proceedings of the 9th Congress of the Medical and Pharmaceutical Society for Wakan Yaku, 1992; p. 95.